PHARMACEUTICAL ECONSULTING A/S: Financial statements 2012
CVR: 30815378
Source: annual report 2012, Danish Business Authority
01/10/2011 – 30/09/2012
PHARMACEUTICAL ECONSULTING A/S (CVR 30815378) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -1,783,587 and a net result of DKK 397,364. Equity in the 2012 report amounted to DKK -1,321,022.
- Gross Profit
- DKK -1,783,587
- Profit/Loss
- DKK 397,364
- Equity
- DKK -1,321,022
- Total Assets
- DKK 3,319,255
Official annual report
Keep an eye on PHARMACEUTICAL ECONSULTING A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout PHARMACEUTICAL ECONSULTING A/S
PHARMACEUTICAL ECONSULTING A/S is a Danish company of the type Aktieselskab based in Glostrup, founded in 2007. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Steen Otto Rugaard. The board consists of Pernille Laurberg Rugaard (chair), Hanne Laurberg Olesen and Steen Otto Rugaard. The company is owned by RUGAARD HOLDING ApS. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 6,113,709 and a net result of DKK -1,066,960 compared with DKK -643,853 the year before. Equity in the 2025 report amounted to DKK 5,152,605.